NORAD promotes multiple myeloma cell progression via BMP6/P-ERK1/2 axis
Multiple myeloma (MM) is one of the most common tumors of the hematological system and remains incurable. Recent studies have shown that long noncoding RNA NORAD is a potential oncogene in a variety of tumors. However, the general biological role and clinical value of NORAD in MM remains unknown. In...
Saved in:
Published in | Cellular signalling Vol. 100; p. 110474 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!